Frontiers in Pharmacology (Jun 2020)

The Natural Polypeptides as Significant Elastase Inhibitors

  • Shabir Ahmad,
  • Shabir Ahmad,
  • Muhammad Saleem,
  • Naheed Riaz,
  • Yong Sup Lee,
  • Reem Diri,
  • Ahmad Noor,
  • Diena Almasri,
  • Alaa Bagalagel,
  • Mahmoud Fahmi Elsebai,
  • Mahmoud Fahmi Elsebai

DOI
https://doi.org/10.3389/fphar.2020.00688
Journal volume & issue
Vol. 11

Abstract

Read online

Human neutrophil elastase (HNE) is a major cause of the destruction of tissues in cases of several different chronic andinflammatory diseases. Overexpression of the elastase enzyme plays a significant role in the pathogenesis of various diseases including chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome, rheumatoid arthritis, the rare disease cyclic hematopoiesis (or cyclic neutropenia), infections, sepsis, cystic fibrosis, myocardial ischemia/reperfusion injury and asthma, inflammation, and atherosclerosis. Human neutrophil elastase is secreted by human neutrophils due to different stimuli. Medicine-based inhibition of the over-activation of neutrophils or production and activity of elastase have been suggested to mend inflammatory diseases. Although the development of new elastase inhibitors is an essential strategy for treating the different inflammatory diseases, it has been a challenge to specifically target the activity of elastase because of its overlapping functions with those of other serine proteases. This review article highlights the reported natural polypeptides as potential inhibitors of elastase enzyme. The mechanism of action, structural features, and activity of the polypeptides have also been correlated wherever they were available.

Keywords